Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells
Kirkin, Alexei F., Dzhandzhugazyan, Karine N., Guldberg, Per, Fang, Johnny Jon, Andersen, Rikke S., Dahl, Christina, Mortensen, Jann, Lundby, Tim, Wagner, Aase, Law, Ian, Broholm, Helle, Madsen, Line, Lundell-Ek, Christer, Gjerstorff, Morten F., Ditzel, Henrik J., Jensen, Martin R., Fischer, Walter
Published in Nature communications (06.03.2018)
Published in Nature communications (06.03.2018)
Get full text
Journal Article
Adoptive T cell cancer therapy
Dzhandzhugazyan, Karine N., Guldberg, Per, Kirkin, Alexei F.
Published in Nature materials (01.06.2018)
Published in Nature materials (01.06.2018)
Get full text
Journal Article
A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma
Werlenius, Katja, Stragliotto, Giuseppe, Strandeus, Michael, Blomstrand, Malin, Carén, Helena, Jakola, Asgeir S, Rydenhag, Bertil, Dyregaard, Dorte, Dzhandzhugazyan, Karine N, Kirkin, Alexei F, Raida, Martin K, Smits, Anja, Kinhult, Sara
Published in Neuro-oncology advances (01.01.2021)
Published in Neuro-oncology advances (01.01.2021)
Get full text
Journal Article
Cancer Testis Antigens: Structural and Immunobiological Properties
Kirkin, Alexei F., Dzhandzhugazyan, Karine N., Zeuthen, Jesper
Published in Cancer investigation (2002)
Published in Cancer investigation (2002)
Get full text
Journal Article
Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas
Dzhandzhugazyan, Karine N, Kirkin, Alexei F, thor Straten, Per, Zeuthen, Jesper
Published in FEBS letters (03.07.1998)
Published in FEBS letters (03.07.1998)
Get full text
Journal Article
Diethyl pyrocarbonate inactivates CD39/ecto-ATPDase by modifying His-59
Dzhandzhugazyan, Karine N., Plesner, Liselotte
Published in Biochimica et biophysica acta (01.06.2000)
Published in Biochimica et biophysica acta (01.06.2000)
Get full text
Journal Article
Establishment of gp100 and MART-1/Melan-A-specific cytotoxic T lymphocyte clones using in vitro immunization against preselected highly immunogenic melanoma cell clones
KIRKIN, A. F, STRATEN, P. T, HANSEN, M. R, BARFOED, A, DZHANDZHUGAZYAN, K. N, ZEUTHEN, J
Published in Cancer Immunology, Immunotherapy (01.08.1999)
Published in Cancer Immunology, Immunotherapy (01.08.1999)
Get full text
Journal Article